-
Recent Posts
- Will ProText Mobility, Inc. (OTCQB: TXTM) Find a Way to Monetize Applications for Mobile Communications Market?
- Can Tranzbyte Corporation (PINKSHEETS: ERBB) Overcome Concerns Surrounding Marijuana Business?
- SoundBite Communications (NASDAQ: SDBT) Surges Following Acquisition Agreement
- Is Regenerative Medicine Realistic for YaFarm Technologies (PINKSHEETS: YFRM)?
- Can Raptor Pharmaceutical Corp. (NASDAQ: RPTP) Turn FDA Approval into Big Payday Down the Road?
Categories
OTC Equity Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
Tags
aapl advertising alternative energy amex apple basic materials biopharmaceutical biotechnology cancer capital goods cloud computing copper drilling energy energy stocks exploration facebook fda fda approval gas gold gold mining google healthcare stocks investors ipad iphone mining NASDAQ natural gas nyse oil oil and gas otcbb penny stock penny stocks petroleum pharmaceutical pinksheets Pink Sheets s silver sprint stocks tradingSite
OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
Registration to our newsletter is FREE, Join today by entering your email below!
Monthly Archives: September 2010
Lingering Concerns Regarding FDA Approval for Surfaxin, Executive Management Shakeup has Discovery Laboratories, Inc. in Precarious Position
The third time is not always the charm and Discovery Laboratories, Inc. (NASDAQ: DSCO), the biotechnology company that has been concentrating on developing surfactant therapies for respiratory diseases, has found this out the hard way. Three times they have taken … Continue reading
Posted in Articles, NASDAQ
Tagged biopharmaceutical, biotechnology, discovery laboratories, dsco, fda, investors, NASDAQ, surfactant, surfaxin
Leave a comment
OTCBB Volume Leaders for Wednesday September 29 Include Wellstar International Inc. (WLSI), Kraig Biocraft Laboratories, Inc. (KBLB), EGPI Firecreek Inc. (EFIR) and Trey Resources, Inc. (TYRIA)
Backed by news that the publication of “Advances of Skin and Wound Care” medical journal has approved the manuscript submitted and will be publishing the results of the Duke Study, Wellstar International, Inc. (OTCBB: WLSI) enjoyed a heavy day of … Continue reading
Posted in News, OTC Bulletin Board
Tagged artfest, arts, efir, egpi firecreek, investors, kblb, kraig biocraft, otcbb, over-the-counter, penny stocks, tyria, volume leaders, wellstar, wlsi
Leave a comment
USA Technologies Inc Shares Climbing Following Record Fourth Quarter Figures, Growth of Wireless Cashless Technologies Continues
There are few penny stocks generating as much buzz as USA Technologies, Inc. (NASDAQ: USAT) as the wireless cashless transactions networker has recently reported impressive revenue growth, gross profit margin and overall penetration in the cashless transactions market. Those factors, … Continue reading
Posted in Articles, NASDAQ
Tagged investors, NASDAQ, penny stocks, revenue growth, stocks, terminals, usa technologies, usat, wireless cash technologies
Leave a comment
Has AVI BioPharma, Inc. Finally Turned a Corner with Positive Results in Duchenne Muscular Dystrophy Studies and Government Funded Testing
For three decades AVI BioPharma, Inc. (NASDAQ: AVII), an RNA-based therapeutics developer, has offered investors little more than potential but the biotech drug company may have finally turned a corner with its recent positive news regarding the treatment of Duchenne … Continue reading
Posted in Articles, NASDAQ
Tagged avi biopharma, avii, biopharmaceutical, biotech, fda, h1n1, influenza, investors, muscular dystrophy, NASDAQ, rna
Leave a comment
Big Day for OTCBB Volume Leaders Unico, Inc (UNCO), Zevotek, Inc. (ZVTK)), Left Behind Games (LFBG), IDO Security, Inc. (IDOI)
Unico, Inc. (OTCBB: UNCO) benefited from a strong performance in the gold market on Tuesday, seeing more than 173 million shares trade hands, more than three times its average, as the price per share moved from 0.0001 to 0.0002 by … Continue reading
Posted in News, OTC Bulletin Board
Tagged ido security, idoi, investors, left behind games, lfbg, otcbb, penny stocks, unco, unico, volume leaders, zevotek, zvtk
Leave a comment
Workforce Reductions, Restructuring Plan and Uncertainty Surrounding Long-Term Strategic Focus Haunting Helicos BioSciences Corporation
It seems that developing the world’s first single molecule sequencing system, the Helicos Genetic Analysis System, would have established Helicos BioSciences Corporation (NASDAQ: HLCS) as a major player in the life sciences industry but since its introduction as a $9.00 … Continue reading
Posted in Articles, NASDAQ
Tagged biopharmaceutical, helicos biosciences, hlcs, investors, life sciences, NASDAQ, single molecule sequencing
Leave a comment
OTCBB Volume Leaders on Monday, September 27, 2010 (ARTS, GELV, INBG, ELCR)
With more than 386 million shares trading hands on Monday, Artfest International (OTCBB: ARTS) was the clear volume leader in OTCBB action as the week got under way. Backed by news that their wholly-owned subsidiary, StarFest Direct, launched its new … Continue reading
Is New Technology for Online Trading Platform the Answer for AlphaTrade.com or will Lingering Questions Keep Investors Away
Last month AlphaTrade.com (OTCBB: APTD), a digital media and marketing company providing financial as well as advertising services, announced in a brief press release that the company was moving forward with the development of new technology that would allow their … Continue reading
Posted in Articles, OTC Bulletin Board
Tagged alphatrade.com, aptd, e-gate, investors, online trading, otcbb, scottrade, smartphones, trading
Leave a comment
Phase 3 Trial of Vosaroxin Gives Sunesis Pharmaceuticals Distinct Advantage for Treatment of First Relapsed or Primary Refractory AML Patients
With Sunesis Pharmaceuticals’ (NASDAQ: SNSS) plans to put their Phase 3 trial known as VALOR (combining their drug Vosaroxin along with Cytarabine) in motion later this year the biopharmaceutical company has taken yet another step in producing a treatment for … Continue reading


